{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:42Z","timestamp":1707525102192},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,17]]},"DOI":"10.7759\/cureus.42003","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T10:52:38Z","timestamp":1689591158000},"source":"Crossref","is-referenced-by-count":1,"title":["Serum Cystatin C Levels as a Predictor of Severity and Mortality Among Patients With COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Kavya","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navikala","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanitha","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Aslam","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb S","year":"2022","unstructured":"Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al.. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022, 19:92. 10.1186\/s12985-022-01814-1","journal-title":"Virol J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang Y","year":"2020","unstructured":"Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020, 11:1708. 10.3389\/fimmu.2020.01708","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1132","article-title":"Cystatin C is a more reliable biomarker for determining eGFR to support drug development studies","volume":"58","author":"Kar S","year":"2018","unstructured":"Kar S, Paglialunga S, Islam R. Cystatin C is a more reliable biomarker for determining eGFR to support drug development studies. J Clin Pharmacol. 2018, 58:1239-47. 10.1002\/jcph.1132","journal-title":"J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR--history, indications, and future research","volume":"38","author":"Filler G","year":"2005","unstructured":"Filler G, B\u00f6kenkamp A, Hofmann W, Le Bricon T, Mart\u00ednez-Br\u00fa C, Grubb A. Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem. 2005, 38:1-8. 10.1016\/j.clinbiochem.2004.09.025","journal-title":"Clin Biochem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2006.10.014","article-title":"How to estimate GFR-serum creatinine, serum cystatin C or equations?","volume":"40","author":"Herget-Rosenthal S","year":"2007","unstructured":"Herget-Rosenthal S, B\u00f6kenkamp A, Hofmann W. How to estimate GFR-serum creatinine, serum cystatin C or equations?. Clin Biochem. 2007, 40:153-61. 10.1016\/j.clinbiochem.2006.10.014","journal-title":"Clin Biochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2018.01.006","article-title":"Involvement of cystatin C in immunity and apoptosis","volume":"196","author":"Zi M","year":"2018","unstructured":"Zi M, Xu Y. Involvement of cystatin C in immunity and apoptosis. Immunol Lett. 2018, 196:80-90. 10.1016\/j.imlet.2018.01.006","journal-title":"Immunol Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2003.031","article-title":"Cystatins C, E\/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders","volume":"384","author":"Werle B","year":"2003","unstructured":"Werle B, Sauckel K, Nathanson CM, Bjarnadottir M, Spiess E, Ebert W, Abrahamson M. Cystatins C, E\/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem. 2003, 384:281-7. 10.1515\/BC.2003.031","journal-title":"Biol Chem"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki R","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, et al.. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021, 184:149-168. 10.1016\/j.cell.2020.11.025","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01139-2","article-title":"Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis","volume":"35","author":"Zinellu A","year":"2022","unstructured":"Zinellu A, Mangoni AA. Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis. J Nephrol. 2022, 35:59-68. 10.1007\/s40620-021-01139-2","journal-title":"J Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.11.038","article-title":"Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19","volume":"46","author":"Barrett B","year":"2021","unstructured":"Barrett B, Pamphile S, Yang F, et al.. Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19. Am J Emerg Med. 2021, 46:595-8. 10.1016\/j.ajem.2020.11.038","journal-title":"Am J Emerg Med"},{"key":"ref12","unstructured":"Clinical guidance for management of adult COVID-19 patients. (2021). Accessed. May 21, 2023: https:\/\/www.icmr.gov.in\/pdf\/covid\/techdoc\/archive\/COVID_Management_Algorithm_23092021.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2019.10.411","article-title":"iNOS as a metabolic enzyme under stress conditions","volume":"146","author":"Anavi S","year":"2020","unstructured":"Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med. 2020, 146:16-35. 10.1016\/j.freeradbiomed.2019.10.411","journal-title":"Free Radic Biol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i20.4726","article-title":"Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19","volume":"8","author":"Li Y","year":"2020","unstructured":"Li Y, Yang S, Peng D, et al.. Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19. World J Clin Cases. 2020, 8:4726-34. 10.12998\/wjcc.v8.i20.4726","journal-title":"World J Clin Cases"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3764515","article-title":"Serum cystatin C and coronavirus disease 2019: a potential inflammatory biomarker in predicting critical illness and mortality for adult patients","volume":"2020","author":"Chen D","year":"2020","unstructured":"Chen D, Sun W, Li J, et al.. Serum cystatin C and coronavirus disease 2019: a potential inflammatory biomarker in predicting critical illness and mortality for adult patients. Mediators Inflamm. 2020, 2020:3764515. 10.1155\/2020\/3764515","journal-title":"Mediators Inflamm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01570-2","article-title":"The predictive value of serum level of cystatin C for COVID-19 severity","volume":"11","author":"Lin L","year":"2021","unstructured":"Lin L, Chen X, Chen J, Pan X, Xia P, Lin H, Du H. The predictive value of serum level of cystatin C for COVID-19 severity. Sci Rep. 2021, 11:21964. 10.1038\/s41598-021-01570-2","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_545_22","article-title":"Role of cystatin C and calprotectin as potential early prognostic biomarkers in COVID-19 patients admitted to a dedicated COVID care facility","volume":"11","author":"Kumar T","year":"2022","unstructured":"Kumar T, Bhushan D, Kumar S, et al.. Role of cystatin C and calprotectin as potential early prognostic biomarkers in COVID-19 patients admitted to a dedicated COVID care facility. J Family Med Prim Care. 2022, 11:3971-9. 10.4103\/jfmpc.jfmpc_545_22","journal-title":"J Family Med Prim Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/168344-serum-cystatin-c-levels-as-a-predictor-of-severity-and-mortality-among-patients-with-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:37Z","timestamp":1707509137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/168344-serum-cystatin-c-levels-as-a-predictor-of-severity-and-mortality-among-patients-with-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.42003","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}